Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Post-Mkt 07-14 17:44:43 EDT

536.17

+5.98

+1.13%

盘后536.17

+0.000.00%

16:11 EDT

High540.15	Low521.46	Vol286.90K
Open530.19	D1 Closing530.19	Amplitude3.53%
Mkt Cap15.31B	Tradable Cap12.34B	Total Shares28.56M
T/O153.62M	T/O Rate1.25%	Tradable Shares23.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":536.17,"timestamp":1784059200000,"preClose":530.19,"halted":0,"volume":286900,"hourTrading":{"tag":"盘后","latestPrice":536.17,"preClose":536.17,"latestTime":"16:11 EDT","volume":4922,"amount":2639028.7399999998,"timestamp":1784059869719,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011278975461626782,"floatShares":23011521,"shares":28558039,"eps":15.90143,"marketStatus":"Post-Mkt","change":5.98,"latestTime":"07-14 17:44:43 EDT","open":530.19,"high":540.1525,"low":521.46,"amount":153624463,"amplitude":0.035256,"askPrice":546.29,"askSize":15,"bidPrice":536.18,"bidSize":7,"shortable":3,"etf":0,"ttmEps":15.90143,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784073600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":530.19,"preHourTrading":{"tag":"盘前","latestPrice":533.01,"preClose":530.19,"latestTime":"09:28 EDT","volume":140,"amount":74562.5356,"timestamp":1784035680020,"change":2.82,"changeRate":0.005319,"amplitude":0.018861},"postHourTrading":{"tag":"盘后","latestPrice":536.17,"preClose":536.17,"latestTime":"16:11 EDT","volume":4922,"amount":2639028.7399999998,"timestamp":1784059869719,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.922566,"impliedVol":0.7014,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"2651911370","title":"Medpace Holdings Inc : Mizuho Raises Target Price to $586 from $495","url":"https://stock-news.laohu8.com/highlight/detail?id=2651911370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651911370?lang=en_us&edition=fundamental","pubTime":"2026-07-13 18:43","pubTimestamp":1783939409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0FI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LU2065170008.USD","BK4585","LU2065171311.SGD","BK4588","MEDP","BK4121","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650925251","title":"TD Cowen Sees Improving Demand for Contract Research Firms in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2650925251","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650925251?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:51","pubTimestamp":1783594264,"startTime":"0","endTime":"0","summary":"BUZZ-TD Cowen sees improving demand for contract research firms in Q2 2026** TD Cowen says improving biotech funding should support stronger demand for contract research organizations, which help drug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nL4N43B0VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0976567544.SGD","LU1201861165.SGD","ICLR","LU1691799644.USD","LU0426417589.USD","LU0708994859.HKD","LU0289960550.SGD","LU0069063385.USD","LU1261432733.SGD","LU2065171402.SGD","MEDP","LU0128525929.USD","LU0029874061.USD","LU0728928796.USD","IQV","LU0477156953.USD","LU0052756011.USD","BK4585","LU0128525689.USD","LU0130103400.USD","LU0187121727.USD","LU0130518102.USD","EKG","LU0289961442.SGD","LU0057025933.USD","LU1201861249.SGD","LU1043141123.HKD","LU0648001328.SGD","LU1267930227.SGD","CRL","LU0128526141.USD","LU0528227936.USD","LU0472753341.HKD","LU1804176565.USD","LU0882574055.USD","LU2265009873.SGD","LU2362541273.HKD","LU1983260115.SGD","LU0477156797.USD","LU0130102774.USD","LU0029864427.USD","LU1791710400.SGD","LU1121112475.USD","LU0648000940.SGD","HEAL","LU0175139822.USD","FTRE","LU0211326755.USD","LU2362540622.SGD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649272993","title":"Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477","url":"https://stock-news.laohu8.com/highlight/detail?id=2649272993","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649272993?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512012,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) has an average rating of Hold and mean price target of $462.55, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649762964","title":"Medpace downgraded to Neutral from Outperform at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2649762964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649762964?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:30","pubTimestamp":1783503009,"startTime":"0","endTime":"0","summary":"Baird analyst Eric Coldwell downgraded Medpace (MEDP) to Neutral from Outperform with a price target of $547, up from $477. not While “not worried”...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-downgraded-to-neutral-from-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-downgraded-to-neutral-from-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649321959","title":"Medpace Shares Fall After Jefferies Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2649321959","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649321959?lang=en_us&edition=fundamental","pubTime":"2026-07-08 03:12","pubTimestamp":1783451542,"startTime":"0","endTime":"0","summary":"Medpace  shares were down 3.7% in Tuesday trading after Jefferies downgraded the company's stock to hold from buy and adjusted its price target to $515 from $490.Trading volume stood at nearly 239,000 shares, compared with a daily average of about 377,000.Price: 545.93, Change: -19.16, Percent Change: -3.39","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649823299","title":"Jefferies Downgrades Medpace Holdings to Hold From Buy, Adjusts Price Target to $515 From $490","url":"https://stock-news.laohu8.com/highlight/detail?id=2649823299","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649823299?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:43","pubTimestamp":1783424588,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) has an average rating of hold and mean price target of $456.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649198622","title":"Medpace Holdings Cut to Hold from Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649198622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649198622?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:59","pubTimestamp":1783418340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings(END) Dow Jones NewswiresJuly 07, 2026 05:59 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","LU2065171402.SGD","BK4121","LU2065170008.USD","LU2065169927.USD","BK4588","BK4585","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649606925","title":"Medpace Holdings Inc : Jefferies Cuts to Hold from Buy; Raises Target Price to $515 from $490","url":"https://stock-news.laohu8.com/highlight/detail?id=2649606925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649606925?lang=en_us&edition=fundamental","pubTime":"2026-07-07 12:12","pubTimestamp":1783397564,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nFWN439036:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LU2065170008.USD","BK4585","LU2065171311.SGD","BK4588","MEDP","BK4121","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160927843","title":"Movement Alert｜Medpace Holdings Rises 7.2% in Regular Trading, Trading at $507.6","url":"https://stock-news.laohu8.com/highlight/detail?id=1160927843","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160927843?lang=en_us&edition=fundamental","pubTime":"2026-06-25 00:14","pubTimestamp":1782317656,"startTime":"0","endTime":"0","summary":"On June 24, Medpace Holdings rose 7.2% in regular trading, trading at $507.6 USD/share, with Turnover of $90.19 million.Within the Life Sciences Tools & Services sector where Medpace Holdings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760522","title":"Medpace to report second-quarter results after market close, host conference call to discuss results","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760522","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760522?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:23","pubTimestamp":1781641395,"startTime":"0","endTime":"0","summary":"Medpace schedules Q2 2026 results for July 22, 2026, released after the market close.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via Business Wire  on June 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3b10db:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MEDP","LU2065171311.SGD","BK4121","LU2065169927.USD","BK4588","LU2065171402.SGD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760514","title":"Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760514?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:23","pubTimestamp":1781641380,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUAVM1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","LU2065170008.USD","BK4121","LU2065171402.SGD","MEDP","LU2065171311.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643731854","title":"Medpace Holdings (MEDP) Stock Valuation Check After Mixed Recent Share Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2643731854","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643731854?lang=en_us&edition=fundamental","pubTime":"2026-06-16 14:27","pubTimestamp":1781591257,"startTime":"0","endTime":"0","summary":"Medpace Holdings overview after recent share performance\nMedpace Holdings (MEDP) has drawn fresh attention after a solid move in its share price over the past month, inviting investors to review how its current valuation lines up with recent fundamentals.\nSee our latest analysis for Medpace Holdings.\nThat recent 12.6% 1 month share price return stands out against a weaker year to date share price return, while a 1 year total shareholder return of 56.9% suggests longer term holders have still...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/medpace-holdings-medp-stock-valuation-check-after-mixed-rece","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/medpace-holdings-medp-stock-valuation-check-after-mixed-rece","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","LU2065170008.USD","BK4585","BK4588","LU2065171311.SGD","MEDP","LU2065169927.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643029412","title":"Pritelivir Trial Update Highlights Medpace’s Role in Drug-Resistant HSV Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2643029412","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643029412?lang=en_us&edition=fundamental","pubTime":"2026-06-13 00:30","pubTimestamp":1781281856,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. Medpace Holdings, Inc. is helping run a Phase 3 trial that tests ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pritelivir-trial-update-highlights-medpaces-role-in-drug-resistant-hsv-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pritelivir-trial-update-highlights-medpaces-role-in-drug-resistant-hsv-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","BK4588","BK4585","LU2065169927.USD","LU2065171402.SGD","BK4121","LU2065171311.SGD","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641454106","title":"How Investors Are Reacting To Medpace Holdings (MEDP) Executive Shakeup Amid Securities Class Action Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2641454106","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641454106?lang=en_us&edition=fundamental","pubTime":"2026-06-08 12:31","pubTimestamp":1780893114,"startTime":"0","endTime":"0","summary":"In early June 2026, Medpace Holdings, Inc. appointed long-time executive Brad W. Hansman as Executive Vice President, Operations, sharing principal operating officer responsibilities alongside Susan E. Burwig.\nAt the same time, Medpace is confronting a wave of securities class action lawsuits alleging misleading statements about backlog cancellations and book-to-bill projections, raising questions about its disclosure practices and governance.\nWe’ll now examine how the surge in securities...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/how-investors-are-reacting-to-medpace-holdings-medp-executiv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/how-investors-are-reacting-to-medpace-holdings-medp-executiv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU2065170008.USD","LU2065169927.USD","BK4121","BK4588","MEDP","LU2065171402.SGD","ISBC","BK4211","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641404167","title":"Medpace Elevates Brad Hansman to Executive Operations Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2641404167","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641404167?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:56","pubTimestamp":1780606577,"startTime":"0","endTime":"0","summary":"Medpace Holdings ( ($MEDP) ) has issued an announcement. Effective June 1, 2026, Medpace Holdings, Inc. appointed long-time executive Brad W. Hansm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medpace-elevates-brad-hansman-to-executive-operations-role?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medpace-elevates-brad-hansman-to-executive-operations-role?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171311.SGD","MEDP","LU2065170008.USD","BK4585","BK4121","BK4588","LU2065171402.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641676111","title":"Medpace says Exec VP of Operations Brad W. Hansman files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2641676111","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641676111?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:44","pubTimestamp":1780605885,"startTime":"0","endTime":"0","summary":"Medpace named Exec. VP of Operations Brad W. Hansman as a reporting officer, disclosing 697 shares held plus RSUs for 5,500 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL5wNP4H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","BK4121","BK4588","LU2065171402.SGD","LU2065170008.USD","LU2065171311.SGD","BK4585","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641626701","title":"Medpace names Brad Hansman executive vice president of operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2641626701","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641626701?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:12","pubTimestamp":1780603929,"startTime":"0","endTime":"0","summary":"Medpace appointed Brad W. Hansman as executive vice president, operations, effective June 1, 2026.Hansman will share principal operating officer duties with Susan E. Burwig, also an executive vice president, operations.He joined in 2011 in finance and accounting, later moved into operations leadership overseeing study start-up, logistics, regulatory affairs.Before Medpace, Hansman worked at Joseph Decosimo as an audit supervisor, earlier held auditor roles at Macy’s.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL4D34bG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4220","BK4588","LU2065171402.SGD","BK4585","BK4103","MEDP","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169688","title":"BEACON Phase III Rugonersen Trial Puts Medpace in Focus for Rare Disease Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169688?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:34","pubTimestamp":1780590855,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. The BEACON Phase III study, titled “A Randomized, Multi-center, D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beacon-phase-iii-rugonersen-trial-puts-medpace-in-focus-for-rare-disease-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beacon-phase-iii-rugonersen-trial-puts-medpace-in-focus-for-rare-disease-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","MEDP","LU2065170008.USD","ISBC","BK4134","BK4211","BK4121","III","BK4588","LU2065169927.USD","BK4585","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640996017","title":"Top Medpace Insider Executes Major Multi-Million Dollar Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2640996017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640996017?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:10","pubTimestamp":1780366202,"startTime":"0","endTime":"0","summary":"New insider activity at Medpace Holdings ( ($MEDP) ) has taken place on June 1, 2026. In a notable insider transaction, Medpace Holdings’ General C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-medpace-insider-executes-major-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-medpace-insider-executes-major-multi-million-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP","LU2065171402.SGD","BK4121","LU2065170008.USD","LU2065169927.USD","BK4588","BK4585","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640736964","title":"Medpace General Counsel Stephen P. Ewald sells 16,349 shares for $7.36 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2640736964","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640736964?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:28","pubTimestamp":1780345728,"startTime":"0","endTime":"0","summary":"Medpace: General Counsel and Corporate Secretary Stephen P. Ewald sold 16,349 shares on May 28 at USD 450.Ewald exercised employee stock options for 16,349 shares the same day at USD 138.87.Directly held common shares fell to 20,343 following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL55PtsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medpace General Counsel Stephen P. Ewald sells 16,349 shares for $7.36 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","BK4588","BK4121","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4585","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":-0.0618},{"period":"1month","weight":0.1345},{"period":"3month","weight":0.0196},{"period":"6month","weight":-0.1399},{"period":"1year","weight":0.6389},{"period":"ytd","weight":-0.056}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.0852},{"period":"1year","weight":0.2013},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006916},{"month":4,"riseRate":0.6,"avgChangeRate":-0.007726},{"month":5,"riseRate":0.5,"avgChangeRate":0.025051},{"month":6,"riseRate":1,"avgChangeRate":0.085381},{"month":7,"riseRate":0.7,"avgChangeRate":0.133399},{"month":8,"riseRate":0.666667,"avgChangeRate":0.032832},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004448},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}